User menu

IL-22, GM-CSF and IL-17 in peripheral CD4+ T cell subpopulations during multiple sclerosis relapses and remission. Impact of corticosteroid therapy.

Bibliographic reference Muls, Nathalie ; Nasr, Zakia ; Dang, Hong Anh ; Sindic, Christian ; Van Pesch, Vincent. IL-22, GM-CSF and IL-17 in peripheral CD4+ T cell subpopulations during multiple sclerosis relapses and remission. Impact of corticosteroid therapy.. In: PLoS One, Vol. 12, no.3, p. e0173780 (2017)
Permanent URL http://hdl.handle.net/2078.1/185961
  1. Komiyama Y., Nakae S., Matsuki T., Nambu A., Ishigame H., Kakuta S., Sudo K., Iwakura Y., IL-17 Plays an Important Role in the Development of Experimental Autoimmune Encephalomyelitis, 10.4049/jimmunol.177.1.566
  2. Cua Daniel J., Sherlock Jonathan, Chen Yi, Murphy Craig A., Joyce Barbara, Seymour Brian, Lucian Linda, To Wayne, Kwan Sylvia, Churakova Tatyana, Zurawski Sandra, Wiekowski Maria, Lira Sergio A., Gorman Daniel, Kastelein Robert A., Sedgwick Jonathon D., Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain, 10.1038/nature01355
  3. Brucklacher-Waldert Verena, Stuerner Klarissa, Kolster Manuela, Wolthausen Julia, Tolosa Eva, Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis, 10.1093/brain/awp289
  4. Matusevicius D, Kivisäkk P, He B, Kostulas N, Özenci V, Fredrikson S, Link H, Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis, 10.1177/135245859900500206
  5. Durelli Luca, Conti Laura, Clerico Marinella, Boselli Daniela, Contessa Giulia, Ripellino Paolo, Ferrero Bruno, Eid Pierre, Novelli Francesco, T-helper 17 cells expand in multiple sclerosis and are inhibited by interferon-β, 10.1002/ana.21652
  6. McQualter Jonathan L., Darwiche Rima, Ewing Christine, Onuki Manabu, Kay Thomas W., Hamilton John A., Reid Hugh H., Bernard Claude C.A., Granulocyte Macrophage Colony-Stimulating Factor : A New Putative Therapeutic Target in Multiple Sclerosis, 10.1084/jem.194.7.873
  7. Vogel Daphne Y. S., Kooij Gijs, Heijnen Priscilla D. A. M., Breur Marjolein, Peferoen Laura A. N., van der Valk Paul, de Vries Helga E., Amor Sandra, Dijkstra Christine D., GM-CSF promotes migration of human monocytes across the blood brain barrier : Molecular immunology, 10.1002/eji.201444960
  8. Croxford Andrew L., Lanzinger Margit, Hartmann Felix J., Schreiner Bettina, Mair Florian, Pelczar Pawel, Clausen Björn E., Jung Steffen, Greter Melanie, Becher Burkhard, The Cytokine GM-CSF Drives the Inflammatory Signature of CCR2+ Monocytes and Licenses Autoimmunity, 10.1016/j.immuni.2015.08.010
  9. Liu Yun, Yang Binyan, Zhou Maohua, Li Li, Zhou Hui, Zhang Jianping, Chen Hui, Wu Changyou, Memory IL‐22‐producing CD4+T cells specific forCandida albicansare present in humans, 10.1002/eji.200838811
  10. Trifari Sara, Kaplan Charles D, Tran Elise H, Crellin Natasha K, Spits Hergen, Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from TH-17, TH1 and TH2 cells, 10.1038/ni.1770
  11. Beyeen A. D., Adzemovic M. Z., Ockinger J., Stridh P., Becanovic K., Laaksonen H., Lassmann H., Harris R. A., Hillert J., Alfredsson L., Celius E. G., Harbo H. F., Kockum I., Jagodic M., Olsson T., IL-22RA2 Associates with Multiple Sclerosis and Macrophage Effector Mechanisms in Experimental Neuroinflammation, 10.4049/jimmunol.1001392
  12. Longhi Maria Serena, Moss Alan, Bai Aiping, Wu Yan, Huang Huang, Cheifetz Adam, Quintana Francisco J., Robson Simon C., Characterization of Human CD39+ Th17 Cells with Suppressor Activity and Modulation in Inflammatory Bowel Disease, 10.1371/journal.pone.0087956
  13. Cortez-Espinosa Nancy, Cortés-Garcia Juan Diego, Martínez-Leija Ernesto, Rodríguez-Rivera Jose Guillermo, Barajas-López Carlos, González-Amaro Roberto, Portales-Pérez Diana Patricia, CD39 expression on Treg and Th17 cells is associated with metabolic factors in patients with type 2 diabetes, 10.1016/j.humimm.2015.09.007
  14. LL Wang, Molecular medicine reports, 8, 1432 (2013)
  15. Martinon Fabio, Mayor Annick, Tschopp Jürg, The Inflammasomes: Guardians of the Body, 10.1146/annurev.immunol.021908.132715
  16. Linden J., Cekic C., Regulation of Lymphocyte Function by Adenosine, 10.1161/atvbaha.111.226837
  17. Muls Nathalie, Jnaoui Karima, Dang Hong Anh, Wauters Antony, Van Snick Jacques, Sindic Christian Jean-Marie, van Pesch Vincent, Upregulation of IL-17, but not of IL-9, in circulating cells of CIS and relapsing MS patients. Impact of corticosteroid therapy on the cytokine network, 10.1016/j.jneuroim.2011.12.010
  18. Gayo Abel, Mozo Lourdes, Suárez Ana, Tuñon Alberto, Lahoz Carlos, Gutiérrez Carmen, Glucocorticoids increase IL-10 expression in multiple sclerosis patients with acute relapse, 10.1016/s0165-5728(97)00262-2
  19. Ossege L.M, Sindern E, Voss B, Malin J.-P, Corticosteroids induce expression of transforming-growth-factor-beta1 mRNA in peripheral blood mononuclear cells of patients with multiple sclerosis, 10.1016/s0165-5728(97)00211-7
  20. NG Muls, Mult Scler (2015)
  21. Polman Chris H., Reingold Stephen C., Banwell Brenda, Clanet Michel, Cohen Jeffrey A., Filippi Massimo, Fujihara Kazuo, Havrdova Eva, Hutchinson Michael, Kappos Ludwig, Lublin Fred D., Montalban Xavier, O'Connor Paul, Sandberg-Wollheim Magnhild, Thompson Alan J., Waubant Emmanuelle, Weinshenker Brian, Wolinsky Jerry S., Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria, 10.1002/ana.22366
  22. Kebir Hania, Kreymborg Katharina, Ifergan Igal, Dodelet-Devillers Aurore, Cayrol Romain, Bernard Monique, Giuliani Fabrizio, Arbour Nathalie, Becher Burkhard, Prat Alexandre, Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation, 10.1038/nm1651
  23. Langrish Claire L., Chen Yi, Blumenschein Wendy M., Mattson Jeanine, Basham Beth, Sedgwick Jonathan D., McClanahan Terrill, Kastelein Robert A., Cua Daniel J., IL-23 drives a pathogenic T cell population that induces autoimmune inflammation, 10.1084/jem.20041257
  24. Constantinescu Cris S., Asher Aliya, Fryze Waldemar, Kozubski Wojciech, Wagner Frank, Aram Jehan, Tanasescu Radu, Korolkiewicz Roman P., Dirnberger-Hertweck Maren, Steidl Stefan, Libretto Susan E., Sprenger Till, Radue Ernst W., Randomized phase 1b trial of MOR103, a human antibody to GM-CSF, in multiple sclerosis, 10.1212/nxi.0000000000000117
  25. Uzawa Akiyuki, Mori Masahiro, Arai Kimihito, Sato Yasunori, Hayakawa Sei, Masuda Saeko, Taniguchi Junko, Kuwabara Satoshi, Cytokine and chemokine profiles in neuromyelitis optica: significance of interleukin-6, 10.1177/1352458510379247
  26. Almolda Beatriz, Costa Manuela, Montoya Maria, González Berta, Castellano Bernardo, Increase in Th17 and T-reg Lymphocytes and Decrease of IL22 Correlate with the Recovery Phase of Acute EAE IN Rat, 10.1371/journal.pone.0027473
  27. Kreymborg K., Etzensperger R., Dumoutier L., Haak S., Rebollo A., Buch T., Heppner F. L., Renauld J.-C., Becher B., IL-22 Is Expressed by Th17 Cells in an IL-23-Dependent Fashion, but Not Required for the Development of Autoimmune Encephalomyelitis, 10.4049/jimmunol.179.12.8098
  28. Rolla S., Bardina V., De Mercanti S., Quaglino P., De Palma R., Gned D., Brusa D., Durelli L., Novelli F., Clerico M., Th22 cells are expanded in multiple sclerosis and are resistant to IFN- , 10.1189/jlb.5a0813-463rr
  29. Brand S., IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration, 10.1152/ajpgi.00513.2005
  30. S Li, Mediators of inflammation, 2012, 260473 (2012)
  31. Lo Yuan-Hsin, Torii Kan, Saito Chiyo, Furuhashi Takuya, Maeda Akira, Morita Akimichi, Serum IL-22 correlates with psoriatic severity and serum IL-6 correlates with susceptibility to phototherapy, 10.1016/j.jdermsci.2010.03.018
  32. He Miao, Liang Peng, IL-24 Transgenic Mice: In Vivo Evidence of Overlapping Functions for IL-20, IL-22, and IL-24 in the Epidermis, 10.4049/jimmunol.0901829
  33. Steiniche Torben, Kragballe Knud, Rømer John, Hasselager Erik, Nørby Peder Lisby, Thorn Clausen Jes, Epidermal Overexpression of Interleukin-19 and -20 mRNA in Psoriatic Skin Disappears After Short-Term Treatment with Cyclosporine A or Calcipotriol, 10.1111/j.1523-1747.2003.12626.x
  34. Andoh A., Shioya M., Nishida A., Bamba S., Tsujikawa T., Kim-Mitsuyama S., Fujiyama Y., Expression of IL-24, an Activator of the JAK1/STAT3/SOCS3 Cascade, Is Enhanced in Inflammatory Bowel Disease, 10.4049/jimmunol.0804169
  35. Esendagli Gunes, Kurne Asli Tuncer, Sayat Guliz, Kilic Ahmet Kasim, Guc Dicle, Karabudak Rana, Evaluation of Th17-related cytokines and receptors in multiple sclerosis patients under interferon beta-1 therapy, 10.1016/j.jneuroim.2012.10.009
  36. El-Behi Mohamed, Ciric Bogoljub, Dai Hong, Yan Yaping, Cullimore Melissa, Safavi Farinaz, Zhang Guang-Xian, Dittel Bonnie N, Rostami Abdolmohamad, The encephalitogenicity of TH17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF, 10.1038/ni.2031
  37. Sheng Wanqiang, Yang Fan, Zhou Yi, Yang Henry, Low Pey Yng, Kemeny David Michael, Tan Patrick, Moh Akira, Kaplan Mark H, Zhang Yongliang, Fu Xin-Yuan, STAT5 programs a distinct subset of GM-CSF-producing T helper cells that is essential for autoimmune neuroinflammation, 10.1038/cr.2014.154
  38. Noster R., Riedel R., Mashreghi M.-F., Radbruch H., Harms L., Haftmann C., Chang H.-D., Radbruch A., Zielinski C. E., IL-17 and GM-CSF Expression Are Antagonistically Regulated by Human T Helper Cells, 10.1126/scitranslmed.3008706
  39. Hirota Keiji, Duarte João H, Veldhoen Marc, Hornsby Eve, Li Ying, Cua Daniel J, Ahlfors Helena, Wilhelm Christoph, Tolaini Mauro, Menzel Ursula, Garefalaki Anna, Potocnik Alexandre J, Stockinger Brigitta, Fate mapping of IL-17-producing T cells in inflammatory responses, 10.1038/ni.1993
  40. H Pan, Cellular & molecular immunology, 1, 43 (2004)
  41. Zenewicz Lauren A., Yancopoulos George D., Valenzuela David M., Murphy Andrew J., Stevens Sean, Flavell Richard A., Innate and Adaptive Interleukin-22 Protects Mice from Inflammatory Bowel Disease, 10.1016/j.immuni.2008.11.003
  42. Wolk Kerstin, Kunz Stefanie, Witte Ellen, Friedrich Markus, Asadullah Khusru, Sabat Robert, IL-22 Increases the Innate Immunity of Tissues, 10.1016/j.immuni.2004.07.007
  43. Sonnenberg Gregory F., Nair Meera G., Kirn Thomas J., Zaph Colby, Fouser Lynette A., Artis David, Pathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17A, 10.1084/jem.20092054
  44. Lee Youjin, Awasthi Amit, Yosef Nir, Quintana Francisco J, Xiao Sheng, Peters Anneli, Wu Chuan, Kleinewietfeld Markus, Kunder Sharon, Hafler David A, Sobel Raymond A, Regev Aviv, Kuchroo Vijay K, Induction and molecular signature of pathogenic TH17 cells, 10.1038/ni.2416
  45. Liang Spencer C., Tan Xiang-Yang, Luxenberg Deborah P., Karim Riyez, Dunussi-Joannopoulos Kyriaki, Collins Mary, Fouser Lynette A., Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides, 10.1084/jem.20061308
  46. Ingwersen J., Wingerath B., Graf J., Lepka K., Hofrichter M., Schröter F., Wedekind F., Bauer A., Schrader J., Hartung H.-P., Prozorovski T., Aktas O., Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation, 10.1186/s12974-016-0512-z
  47. Pan Hai-Feng, Li Xiang-Pei, Zheng Song Guo, Ye Dong-Qing, Emerging role of interleukin-22 in autoimmune diseases, 10.1016/j.cytogfr.2012.07.002
  48. Iudicibus Sara De, Molecular mechanism of glucocorticoid resistance in inflammatory bowel disease, 10.3748/wjg.v17.i9.1095
  49. Ramesh Radha, Kozhaya Lina, McKevitt Kelly, Djuretic Ivana M., Carlson Thaddeus J., Quintero Maria A., McCauley Jacob L., Abreu Maria T., Unutmaz Derya, Sundrud Mark S., Pro-inflammatory human Th17 cells selectively express P-glycoprotein and are refractory to glucocorticoids, 10.1084/jem.20130301
  50. CC Gross, Mult Scler (2016)
  51. Perriard Guillaume, Mathias Amandine, Enz Lukas, Canales Mathieu, Schluep Myriam, Gentner Melanie, Schaeren-Wiemers Nicole, Du Pasquier Renaud A., Interleukin-22 is increased in multiple sclerosis patients and targets astrocytes, 10.1186/s12974-015-0335-3